- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Eine wichtige Zusammenstellung von Beiträgen zur Toxikogenomik für Toxikologen und verwandte Wissenschaftler.
Andere Kunden interessierten sich auch für
- Drug Metabolism in Drug Design and Development197,99 €
- Dimitri SemizarovGenomics Drug Discovery191,99 €
- Drug-Induced Mitochondrial Dysfunction238,99 €
- Toxicogenomics165,99 €
- Ene I. Ette / Paul J. Williams (eds.)Pharmacometrics281,99 €
- Formulation and Analytical Development for Low-Dose Oral Drug Products167,99 €
- Eric M. Gordon / James F. Kerwin (Hgg.)Combinatorial Chemistry and Molecular Diversity in Drug Discovery246,99 €
-
-
-
Eine wichtige Zusammenstellung von Beiträgen zur Toxikogenomik für Toxikologen und verwandte Wissenschaftler.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Wiley & Sons
- 1. Auflage
- Seitenzahl: 422
- Erscheinungstermin: 24. November 2008
- Englisch
- Abmessung: 249mm x 175mm x 28mm
- Gewicht: 886g
- ISBN-13: 9780470518236
- ISBN-10: 0470518235
- Artikelnr.: 25055337
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
- Verlag: Wiley & Sons
- 1. Auflage
- Seitenzahl: 422
- Erscheinungstermin: 24. November 2008
- Englisch
- Abmessung: 249mm x 175mm x 28mm
- Gewicht: 886g
- ISBN-13: 9780470518236
- ISBN-10: 0470518235
- Artikelnr.: 25055337
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- 06621 890
Dr. Saura C. Sahu, Research Chemist, Division of Toxicology, Office of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, US Food and Drug Administration. Dr. Sahu is the US Editor for the Journal of Applied Toxicology and the editor of Hepatotoxicity (Wiley, Dec 2007).
1. Mechanistic toxicogenomics: Design and analysis of microarray
experiments (Kirstin Meyer, Susanne Schwenke and Johanna M. Beekman).
2. Analysis and interpretation of toxicogenomic data: Biological responses
to low, environmentally-relevant doses of toxicants (Julia A. Gosse,
Jennifer Davey, Thomas Hampton and Joshua Hamilton).
3. Principles of data-mining in toxicogenomics (Yoko Hirabayashi and Tohru
Inoue).
4. Design issues in toxicogenomics studies: The application of genomic
technologies for mechanistic and predictive research (Woong-Yang Park, Lian
Li and Daehee Kang).
5. Sources of variability in toxicogenomic assays (Karol Thompson, P. Scott
Pine and Barry Rosenzweig).
6. Key aspects of toxicogenomic data analysis and interpretation as a
safety assessment tool to identify and understand drug-induced toxicity
(Antoaneta Vladimirova and Brigitte Ganter).
7. Toxicogenomics as a tool to assess immunotoxicity (Kirsten Baken, J.
Ezendam, J. Pennings, R. Vandebriel,and H. Loveren).
8. Toxicogenomics and ecogenomics for studying endocrine disruption and
basic biology (Taisen Iguchi, Hajime Watanabe and Yoshino Kata).
9. Gene expression profiling of transplacental arsenic carcinogenesis in
mice (Jie Liu, B. Diwan, R. Tennant and Michael Waalkes).
10. Characterization of estrogen active compounds and estrogenic signaling
by global gene expression profiling in vitro (Stephanie Simon, Kathleen
Boehme, Susanne Schmidt and Stephan Mueller).
11. Escherichia coli stress response as a tool for detection of toxicity
(Arindam Mitra, Nabarun Chakraborti and Suman Mukhopadhyay).
12. Toxicogenomics in vitro: A powerful tool for screening hepatotoxic
potential of food-related products (Saura C. Sahu).
13. Toxicogenomics approach to drug-induced phospholipidosis (Hiroshi
Sawada).
14. Use of toxicogenomics as an early predictive tool for Hepatotoxicity
(Laura Suter).
15. Nutrigenomics: The application of genomic signatures in
nutrition-related research (Stamotis Theocharis and Elisavet Gatzidou).
16. Application of toxicogenomics in drug discovery (Michael Liguori, Amy
Ditewig and Jeffery Waring).
17. Natural products from medicinal plants and risk assessment (Leila
Chekir-Ghedira).
18. The development of a metabonomic-based drug safety testing paradigm
(Muireann Coen, Elaine Holms, Jeremy Nicholson and John Lindon).
19. Potential Uses of Toxicogenomic Biomarkers in Occupational Health and
Risk Assessment (Paul A. Nony).
20. Usefulness of toxicogenomics in the regulatory environment (Daniel
Casciano).
21. Toxicogenomics for regulatory use: the view from the bench (P. Ancian,
S.Leuillett, S. Artaud, J. Jegard and Roy Forster).
22. Perspectives on toxicogenomics at the US Environmental Protection
Agency (Karen Hamernik, Kenneth Haymes, Susan Hester and Thomas
McClintock).
experiments (Kirstin Meyer, Susanne Schwenke and Johanna M. Beekman).
2. Analysis and interpretation of toxicogenomic data: Biological responses
to low, environmentally-relevant doses of toxicants (Julia A. Gosse,
Jennifer Davey, Thomas Hampton and Joshua Hamilton).
3. Principles of data-mining in toxicogenomics (Yoko Hirabayashi and Tohru
Inoue).
4. Design issues in toxicogenomics studies: The application of genomic
technologies for mechanistic and predictive research (Woong-Yang Park, Lian
Li and Daehee Kang).
5. Sources of variability in toxicogenomic assays (Karol Thompson, P. Scott
Pine and Barry Rosenzweig).
6. Key aspects of toxicogenomic data analysis and interpretation as a
safety assessment tool to identify and understand drug-induced toxicity
(Antoaneta Vladimirova and Brigitte Ganter).
7. Toxicogenomics as a tool to assess immunotoxicity (Kirsten Baken, J.
Ezendam, J. Pennings, R. Vandebriel,and H. Loveren).
8. Toxicogenomics and ecogenomics for studying endocrine disruption and
basic biology (Taisen Iguchi, Hajime Watanabe and Yoshino Kata).
9. Gene expression profiling of transplacental arsenic carcinogenesis in
mice (Jie Liu, B. Diwan, R. Tennant and Michael Waalkes).
10. Characterization of estrogen active compounds and estrogenic signaling
by global gene expression profiling in vitro (Stephanie Simon, Kathleen
Boehme, Susanne Schmidt and Stephan Mueller).
11. Escherichia coli stress response as a tool for detection of toxicity
(Arindam Mitra, Nabarun Chakraborti and Suman Mukhopadhyay).
12. Toxicogenomics in vitro: A powerful tool for screening hepatotoxic
potential of food-related products (Saura C. Sahu).
13. Toxicogenomics approach to drug-induced phospholipidosis (Hiroshi
Sawada).
14. Use of toxicogenomics as an early predictive tool for Hepatotoxicity
(Laura Suter).
15. Nutrigenomics: The application of genomic signatures in
nutrition-related research (Stamotis Theocharis and Elisavet Gatzidou).
16. Application of toxicogenomics in drug discovery (Michael Liguori, Amy
Ditewig and Jeffery Waring).
17. Natural products from medicinal plants and risk assessment (Leila
Chekir-Ghedira).
18. The development of a metabonomic-based drug safety testing paradigm
(Muireann Coen, Elaine Holms, Jeremy Nicholson and John Lindon).
19. Potential Uses of Toxicogenomic Biomarkers in Occupational Health and
Risk Assessment (Paul A. Nony).
20. Usefulness of toxicogenomics in the regulatory environment (Daniel
Casciano).
21. Toxicogenomics for regulatory use: the view from the bench (P. Ancian,
S.Leuillett, S. Artaud, J. Jegard and Roy Forster).
22. Perspectives on toxicogenomics at the US Environmental Protection
Agency (Karen Hamernik, Kenneth Haymes, Susan Hester and Thomas
McClintock).
1. Mechanistic toxicogenomics: Design and analysis of microarray
experiments (Kirstin Meyer, Susanne Schwenke and Johanna M. Beekman).
2. Analysis and interpretation of toxicogenomic data: Biological responses
to low, environmentally-relevant doses of toxicants (Julia A. Gosse,
Jennifer Davey, Thomas Hampton and Joshua Hamilton).
3. Principles of data-mining in toxicogenomics (Yoko Hirabayashi and Tohru
Inoue).
4. Design issues in toxicogenomics studies: The application of genomic
technologies for mechanistic and predictive research (Woong-Yang Park, Lian
Li and Daehee Kang).
5. Sources of variability in toxicogenomic assays (Karol Thompson, P. Scott
Pine and Barry Rosenzweig).
6. Key aspects of toxicogenomic data analysis and interpretation as a
safety assessment tool to identify and understand drug-induced toxicity
(Antoaneta Vladimirova and Brigitte Ganter).
7. Toxicogenomics as a tool to assess immunotoxicity (Kirsten Baken, J.
Ezendam, J. Pennings, R. Vandebriel,and H. Loveren).
8. Toxicogenomics and ecogenomics for studying endocrine disruption and
basic biology (Taisen Iguchi, Hajime Watanabe and Yoshino Kata).
9. Gene expression profiling of transplacental arsenic carcinogenesis in
mice (Jie Liu, B. Diwan, R. Tennant and Michael Waalkes).
10. Characterization of estrogen active compounds and estrogenic signaling
by global gene expression profiling in vitro (Stephanie Simon, Kathleen
Boehme, Susanne Schmidt and Stephan Mueller).
11. Escherichia coli stress response as a tool for detection of toxicity
(Arindam Mitra, Nabarun Chakraborti and Suman Mukhopadhyay).
12. Toxicogenomics in vitro: A powerful tool for screening hepatotoxic
potential of food-related products (Saura C. Sahu).
13. Toxicogenomics approach to drug-induced phospholipidosis (Hiroshi
Sawada).
14. Use of toxicogenomics as an early predictive tool for Hepatotoxicity
(Laura Suter).
15. Nutrigenomics: The application of genomic signatures in
nutrition-related research (Stamotis Theocharis and Elisavet Gatzidou).
16. Application of toxicogenomics in drug discovery (Michael Liguori, Amy
Ditewig and Jeffery Waring).
17. Natural products from medicinal plants and risk assessment (Leila
Chekir-Ghedira).
18. The development of a metabonomic-based drug safety testing paradigm
(Muireann Coen, Elaine Holms, Jeremy Nicholson and John Lindon).
19. Potential Uses of Toxicogenomic Biomarkers in Occupational Health and
Risk Assessment (Paul A. Nony).
20. Usefulness of toxicogenomics in the regulatory environment (Daniel
Casciano).
21. Toxicogenomics for regulatory use: the view from the bench (P. Ancian,
S.Leuillett, S. Artaud, J. Jegard and Roy Forster).
22. Perspectives on toxicogenomics at the US Environmental Protection
Agency (Karen Hamernik, Kenneth Haymes, Susan Hester and Thomas
McClintock).
experiments (Kirstin Meyer, Susanne Schwenke and Johanna M. Beekman).
2. Analysis and interpretation of toxicogenomic data: Biological responses
to low, environmentally-relevant doses of toxicants (Julia A. Gosse,
Jennifer Davey, Thomas Hampton and Joshua Hamilton).
3. Principles of data-mining in toxicogenomics (Yoko Hirabayashi and Tohru
Inoue).
4. Design issues in toxicogenomics studies: The application of genomic
technologies for mechanistic and predictive research (Woong-Yang Park, Lian
Li and Daehee Kang).
5. Sources of variability in toxicogenomic assays (Karol Thompson, P. Scott
Pine and Barry Rosenzweig).
6. Key aspects of toxicogenomic data analysis and interpretation as a
safety assessment tool to identify and understand drug-induced toxicity
(Antoaneta Vladimirova and Brigitte Ganter).
7. Toxicogenomics as a tool to assess immunotoxicity (Kirsten Baken, J.
Ezendam, J. Pennings, R. Vandebriel,and H. Loveren).
8. Toxicogenomics and ecogenomics for studying endocrine disruption and
basic biology (Taisen Iguchi, Hajime Watanabe and Yoshino Kata).
9. Gene expression profiling of transplacental arsenic carcinogenesis in
mice (Jie Liu, B. Diwan, R. Tennant and Michael Waalkes).
10. Characterization of estrogen active compounds and estrogenic signaling
by global gene expression profiling in vitro (Stephanie Simon, Kathleen
Boehme, Susanne Schmidt and Stephan Mueller).
11. Escherichia coli stress response as a tool for detection of toxicity
(Arindam Mitra, Nabarun Chakraborti and Suman Mukhopadhyay).
12. Toxicogenomics in vitro: A powerful tool for screening hepatotoxic
potential of food-related products (Saura C. Sahu).
13. Toxicogenomics approach to drug-induced phospholipidosis (Hiroshi
Sawada).
14. Use of toxicogenomics as an early predictive tool for Hepatotoxicity
(Laura Suter).
15. Nutrigenomics: The application of genomic signatures in
nutrition-related research (Stamotis Theocharis and Elisavet Gatzidou).
16. Application of toxicogenomics in drug discovery (Michael Liguori, Amy
Ditewig and Jeffery Waring).
17. Natural products from medicinal plants and risk assessment (Leila
Chekir-Ghedira).
18. The development of a metabonomic-based drug safety testing paradigm
(Muireann Coen, Elaine Holms, Jeremy Nicholson and John Lindon).
19. Potential Uses of Toxicogenomic Biomarkers in Occupational Health and
Risk Assessment (Paul A. Nony).
20. Usefulness of toxicogenomics in the regulatory environment (Daniel
Casciano).
21. Toxicogenomics for regulatory use: the view from the bench (P. Ancian,
S.Leuillett, S. Artaud, J. Jegard and Roy Forster).
22. Perspectives on toxicogenomics at the US Environmental Protection
Agency (Karen Hamernik, Kenneth Haymes, Susan Hester and Thomas
McClintock).